University of Alabama at Birmingham to Enroll Patients in Pilot Study Using Mytrus and its iPad Application

Article

Company News Release

Mytrus, an innovative clinical technology and services company for medical and pharmaceutical research, today announced that the University of Alabama at Birmingham (UAB) will use its iPad® application in an upcoming pilot study supported by the U.S. Department of Health & Human Services Agency for Healthcare Research and Quality. UAB is evaluating how digital tools might simplify enrollment and enhance patient understanding during the informed consent process. Kenneth G. Saag, MD, Msc, professor in the UAB Department of Medicine, will lead the study.

For more specific information on UAB’s usage of the Mytrus iPad application, read UAB’s article, “UAB studying high tech way to secure informed consent in research trials” by Bob Shepard, published earlier this month.

Using animation and other visual imagery, the Mytrus iPad application is the first in the industry to condense the complex and critical disclosure information required at the start of a clinical trial into an easy-to-understand, digitized format. This new approach not only helps patients better understand the clinical trial process; it helps researchers gain valuable insight into the speed and effectiveness of the informed consent process in multi-center studies.

“The Mytrus application gives study sponsors a window into the informed consent process that they’ve never had before,” said Anthony Costello, CEO of Mytrus. “Like many sponsors we work with, the University of Alabama at Birmingham also recognizes that increasing a patient’s understanding and comfort level during consent is the best way to retain highly motivated and protocol compliant patients throughout the study.”

Related Links:

An Idea Whose Time Came

Greenphire and Mytrus Partner to Provide Web-based Solutions for Patient Recruitment and Retention

 

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.